Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Vyvanse (lisdexamfetamine) and Concerta (methylphenidate extended-release) are both stimulant medications that treat ADHD. Vyvanse is also FDA approved for binge-eating disorder. Vyvanse and Concerta are different types of stimulants: Vyvanse is an amphetamine and Concerta is a methylphenidate. They’re both long-acting, or extended-release (ER), medications that are typically taken once a day. Vyvanse and Concerta have similar side effects such as low appetite and headache. And they’re both controlled substances, which means they can lead to dependence and misuse. Taking them only as prescribed can help decrease these risks.
Vyvanse (lisdexamfetamine)
Methylphenidate er
Vyvanse (lisdexamfetamine)
Methylphenidate er
Summary of Vyvanse vs. Concerta
Summary for Stimulant
Prescription only
Vyvanse, the brand name for lisdexamfetamine, is a stimulant medication. It's used to treat attention deficit-hyperactivity disorder (ADHD) in people 6 years and older. It can also treat binge eating disorder (BED) in adults. Vyvanse (lisdexamfetamine) comes as capsules and chewable tablets. It's taken once per day in the morning. The dosage starts low and gets adjusted based on how you respond to the medication. Common side effects include trouble sleeping and loss of appetite. Vyvanse (lisdexamfetamine) is a controlled substance because it has a high risk of misuse and dependency.
Summary for Stimulant
Prescription only
Methylphenidate extended-release (ER) is a first-choice option for people with attention deficit-hyperactivity disorder (ADHD). This once-daily medication can start to work within 2 hours and can last throughout the day. Methylphenidate ER can cause difficulty sleeping and a loss of appetite. It also has a potential risk of misuse and dependency and is thus a controlled substance.